CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Berberine

黄莲素 杂质对照品Berberine Impurities

43 个杂质条目43 impurity entries

本页汇总 黄莲素 的 43 个杂质对照品条目。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 43 impurity reference standards of Berberine. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 黄莲素(Berberine)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesBerberine sensitizes liver cancer cells to sorafenib by inducing SETDB1/NQO1/p53-dependent ferroptosis and genomic instability
    European journal of pharmacology · 2025 · Li K et al.  ·  PMID 41082996  ·  DOI
  2. 杂质研究Impurity studiesRethinking Synthetic Berberine in Nutraceuticals: Nitrosamine Risks, Regulatory Oversight, and Safer Alternatives
    Molecules (Basel, Switzerland) · 2025 · Meher AK et al.  ·  PMID 41226233  ·  DOI
  3. 杂质研究Impurity studiesBerberine, a genotoxic alkaloid, induces ATM-Chk1 mediated G2 arrest in prostate cancer cells
    Mutation research · 2012 · Wang Y et al.  ·  PMID 22561209  ·  DOI

合成路线参考Reported synthetic routes

以下为公开文献中报道的合成方法(题录信息)。标题多已点明关键反应,可据此查阅原文了解完整路线与工艺条件。Published synthetic approaches. Titles usually name the key transformation; consult the original articles for full routes.

  • 合成方法SynthesisSynthesis of N-Mannich bases of berberine linking piperazine moieties revealing anticancer and antioxidant effects
    Saudi journal of biological sciences · 2017 · Mistry B et al.  ·  PMID 28053569  ·  DOI
  • 合成方法SynthesisCytotoxicity evaluation of natural coptisine and synthesis of coptisine from berberine
    Farmaco (Societa chimica italiana : 1989) · 2001 · Colombo ML et al.  ·  PMID 11482767  ·  DOI

黄莲素 —— 原料药与杂质对照品Berberine — drug substance & impurities

共 43 个条目(含原料药本体)43 items incl. the drug substance
Berberine Impurity 1 structure
1
黄莲素杂质1Berberine Impurity 1
Berberine Impurity 1
CAS No.1095271-88-7
Chemical FormulaC26H27NO6S
Purity>95%询价On request
10mg25mg50mg100mg
Berberine Impurity 2 structure
2
黄莲素杂质2Berberine Impurity 2
Berberine Impurity 2
CAS No.248262-61-5
Chemical FormulaC19H18ClNO4
Purity>95%询价On request
10mg25mg50mg100mg
Berberine Impurity 3 structure
3
黄莲素杂质3Berberine Impurity 3
Berberine Impurity 3
CAS No.38691-95-1
Chemical FormulaC19H16BrNO4
Purity>95%询价On request
10mg25mg50mg100mg
Berberine Impurity 4 structure
4
黄莲素杂质4Berberine Impurity 4
Berberine Impurity 4
CAS No.125727-33-5
Chemical FormulaC19H16BrNO4
Purity>95%询价On request
10mg25mg50mg100mg
Berberine Impurity 5 structure
5
黄莲素杂质5Berberine Impurity 5
Berberine Impurity 5
CAS No.1325581-71-2
Chemical FormulaC20H18NO5+
Purity>95%询价On request
10mg25mg50mg100mg
Berberine Impurity 6 structure
6
黄莲素杂质6Berberine Impurity 6
Berberine Impurity 6
CAS No.430433-40-2
Chemical FormulaC18H21NO4·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Berberine Impurity 7 structure
7
黄莲素杂质7Berberine Impurity 7
Berberine Impurity 7
CAS No.2043361-62-0
Chemical FormulaC20H18NO5+
Purity>95%询价On request
10mg25mg50mg100mg
Berberine Impurity 8 structure
8
黄莲素杂质8Berberine Impurity 8
Berberine Impurity 8
CAS No.7664-25-7
Chemical FormulaC20H18NO5+·Cl-
Purity>95%询价On request
10mg25mg50mg100mg
Berberine Impurity 9 structure
9
黄莲素杂质9Berberine Impurity 9
Berberine Impurity 9
CAS No.24211-36-7
Chemical FormulaC22H18O6
Purity>95%询价On request
10mg25mg50mg100mg
Berberine Impurity 10 Monomer structure
10
黄莲素杂质10 单体Berberine Impurity 10 Monomer
Berberine Impurity 10 Monomer
CAS No.19716-67-7
Chemical FormulaC19H14NO4+
Purity>95%询价On request
10mg25mg50mg100mg
Berberine Impurity 10 structure
10
黄莲素杂质10Berberine Impurity 10
Berberine Impurity 10
CAS No.30044-78-1
Chemical FormulaC19H14NO4+·Cl-
Purity>95%询价On request
10mg25mg50mg100mg
Berberine Impurity 12 Monomer structure
12
黄莲素杂质12 单体Berberine Impurity 12 Monomer
Berberine Impurity 12 Monomer
CAS No.112077-81-3
Chemical FormulaC20H16NO4+
Purity>95%询价On request
10mg25mg50mg100mg
Berberine Impurity 12 structure
12
黄莲素杂质12Berberine Impurity 12
Berberine Impurity 12
CAS No.55971-02-3
Chemical FormulaC20H16NO4+·Cl-
Purity>95%询价On request
10mg25mg50mg100mg
Berberine Impurity 13 structure
13
黄莲素杂质13Berberine Impurity 13
Berberine Impurity 13
CAS No.16705-03-6
Chemical FormulaC19H18NO4+·Cl-
Purity>95%询价On request
10mg25mg50mg100mg
Berberine Impurity 14 Monomer structure
14
黄莲素杂质14 单体Berberine Impurity 14 Monomer
Berberine Impurity 14 Monomer
CAS No.18207-71-1
Chemical FormulaC19H16NO4+
Purity>95%询价On request
10mg25mg50mg100mg
Berberine Impurity 14 structure
14
黄莲素杂质14Berberine Impurity 14
Berberine Impurity 14
CAS No.4668-19-3
Chemical FormulaC19H16ClNO4
Purity>95%询价On request
10mg25mg50mg100mg
Berberine Impurity 15 structure
15
黄莲素杂质15Berberine Impurity 15
Berberine Impurity 15
CAS No.38763-29-0
Chemical FormulaC20H16NO4+
Purity>95%询价On request
10mg25mg50mg100mg
Berberine Impurity 16 structure
16
黄莲素杂质16Berberine Impurity 16
Berberine Impurity 16
CAS No.1233353-87-1
Chemical FormulaC25H24FNO5S
Purity>95%询价On request
10mg25mg50mg100mg
Berberine Impurity 17 structure
17
黄莲素杂质17Berberine Impurity 17
Berberine Impurity 17
CAS No.30413-84-4
Chemical FormulaC20H23NO4
Purity>95%询价On request
10mg25mg50mg100mg
Berberine Impurity 18 structure
18
黄莲素杂质18Berberine Impurity 18
Berberine Impurity 18
CAS No.19716-61-1
Chemical FormulaC19H13NO5
Purity>95%询价On request
10mg25mg50mg100mg
Berberine Impurity 19 structure
19
黄莲素杂质19Berberine Impurity 19
Berberine Impurity 19
CAS No.6451-73-6
Chemical FormulaC19H21NO4
Purity>95%询价On request
10mg25mg50mg100mg
Berberine Impurity 20 structure
20
黄莲素杂质20Berberine Impurity 20
Berberine Impurity 20
CAS No.18090-68-1
Chemical FormulaC20H23NO4
Purity>95%询价On request
10mg25mg50mg100mg
Berberine Impurity 21 structure
21
黄莲素杂质21Berberine Impurity 21
Berberine Impurity 21
CAS No.483-34-1
Chemical FormulaC20H23NO4
Purity>95%询价On request
10mg25mg50mg100mg
Berberine Impurity 22 structure
22
黄莲素杂质22Berberine Impurity 22
Berberine Impurity 22
CAS No.5096-57-1
Chemical FormulaC20H21NO4
Purity>95%询价On request
10mg25mg50mg100mg
Berberine Impurity 23 structure
23
黄莲素杂质23Berberine Impurity 23
Berberine Impurity 23
CAS No.33469-94-2
Chemical FormulaC20H18NO5+·I-
Purity>95%询价On request
10mg25mg50mg100mg
Berberine Impurity 24 Chloride structure
24
黄莲素杂质24 氯化物Berberine Impurity 24 Chloride
Berberine Impurity 24 Chloride
CAS No.1065581-69-2
Chemical FormulaC19H16NO4+·Cl-
Purity>95%询价On request
10mg25mg50mg100mg
Berberine Impurity 24 structure
24
黄莲素杂质24Berberine Impurity 24
Berberine Impurity 24
CAS No.1065849-28-6
Chemical FormulaC19H16NO4+
Purity>95%询价On request
10mg25mg50mg100mg
Berberine Impurity 25 structure
25
黄莲素杂质25Berberine Impurity 25
Berberine Impurity 25
CAS No.17388-19-1
Chemical FormulaC19H16NO4+
Purity>95%询价On request
10mg25mg50mg100mg
Berberine Impurity 26 structure
26
黄莲素杂质26Berberine Impurity 26
Berberine Impurity 26
CAS No.19716-72-4
Chemical FormulaC20H18NO4+
Purity>95%询价On request
10mg25mg50mg100mg
Berberine Impurity 26 Chloride structure
26
黄莲素杂质26 氯化物Berberine Impurity 26 Chloride
Berberine Impurity 26 Chloride
CAS No.55323-32-5
Chemical FormulaC20H18NO4+·Cl-
Purity>95%询价On request
10mg25mg50mg100mg
Berberine Impurity 27 structure
27
黄莲素杂质27Berberine Impurity 27
Berberine Impurity 27
CAS No.62595-72-6
Chemical FormulaC20H17NO5
Purity>95%询价On request
10mg25mg50mg100mg
Berberine Impurity 28 structure
28
黄莲素杂质28Berberine Impurity 28
Berberine Impurity 28
CAS No.1186107-72-1
Chemical FormulaC18H16NO4+·Cl-
Purity>95%询价On request
10mg25mg50mg100mg
Berberine Impurity 31 structure
31
黄莲素杂质31Berberine Impurity 31
Berberine Impurity 31
CAS No.2363741-22-2
Chemical FormulaC18H16NO4+·Cl-
Purity>95%询价On request
10mg25mg50mg100mg
Berberine Impurity 32 structure
32
黄莲素杂质32Berberine Impurity 32
Berberine Impurity 32
CAS No.41759-65-3
Chemical FormulaC20H18NO5+·I-
Purity>95%询价On request
10mg25mg50mg100mg
Berberine Impurity 33 structure
33
黄莲素杂质33Berberine Impurity 33
Berberine Impurity 33
CAS No.138664-32-1
Chemical FormulaC19H19NO4
Purity>95%询价On request
10mg25mg50mg100mg
Berberine Impurity 36 structure
36
黄莲素杂质36Berberine Impurity 36
Berberine Impurity 36
CAS No.2648606-63-5
Chemical FormulaC18H19NO4
Purity>95%询价On request
10mg25mg50mg100mg
Berberine Impurity 37 structure
37
黄莲素杂质37Berberine Impurity 37
Berberine Impurity 37
CAS No.5653-67-8
Chemical FormulaC9H12O3
Purity>95%询价On request
10mg25mg50mg100mg
Berberine Impurity 38 structure
38
黄莲素杂质38Berberine Impurity 38
Berberine Impurity 38
CAS No.87168-75-0
Chemical FormulaC20H19NO6
Purity>95%询价On request
10mg25mg50mg100mg
Berberine Impurity 39 structure
39
黄莲素杂质39Berberine Impurity 39
Berberine Impurity 39
CAS No.1428907-26-9
Chemical FormulaC17H21NO4
Purity>95%询价On request
10mg25mg50mg100mg
Berberine Impurity 40 structure
40
黄莲素杂质40Berberine Impurity 40
Berberine Impurity 40
CAS No.1428907-25-8
Chemical FormulaC18H23NO4
Purity>95%询价On request
10mg25mg50mg100mg
Berberine Impurity 42 structure
42
黄莲素杂质42Berberine Impurity 42
Berberine Impurity 42
CAS No.47355-66-8
Chemical FormulaC19H25NO4
Purity>95%询价On request
10mg25mg50mg100mg
Berberine Impurity 43 structure
43
黄莲素杂质43Berberine Impurity 43
Berberine Impurity 43
CAS No.100101-07-3
Chemical FormulaC20H21NO5
Purity>95%询价On request
10mg25mg50mg100mg
Berberine Impurity 44 structure
44
黄莲素杂质44Berberine Impurity 44
Berberine Impurity 44
CAS No.1093513-74-6
Chemical FormulaC19H17NO7S
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

黄莲素 —— 研究文献与合成路线Berberine — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 黄莲素 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Berberine. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Berberine Derivative B68 Promotes Tumor Immune Clearance by Dual-Targeting BMI1 for Senescence Induction and CSN5 for PD-L1 Degradation
    Hu H, Wang Q, Yu D, et al. · Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025 · 被引 22cited 22
  2. Berberine alleviates endothelial glycocalyx degradation and promotes glycocalyx restoration in LPS-induced ARDS
    Huang L, Zhang X, Ma X, et al. · International immunopharmacology · 2018 · 被引 48cited 48
  3. Isolation and Characterization of a Bacterial Strain Capable of Efficient Berberine Degradation
    Liu S, Zhang Y, Zeng P, et al. · International journal of environmental research and public health · 2019 · 被引 11cited 11
  4. Autophagic degradation of LOX-1 is involved in the maintenance of vascular integrity injured by oxLDL and protected by Berberine
    Zheng Y, Chen B, Zhang M, et al. · International journal of biological sciences · 2023 · 被引 9cited 9
  5. Stability Indicating Eco Friendly UV Spectrophotometric Determination of Berberine Hydrochloride Using Quality by Design and AGREE Approach
    Maroor MT, Shetti PPSDPP, Karande SM, et al. · 2026
  6. Berberine, a natural molecular glue degrader, overcomes CML resistance via TRIM28-mediated HIF1α ubiquitination and subsequent ferroptosis
    Su R, Xu R, Shi W, et al. · Cell reports · 2026

合成与制备工艺专利Synthesis & process patents

  1. Berberine compounds and processes for the preparation of berberine compounds
    GROTE CHRISTOPHER W, MOSER FRANK W, JOHNSON JR JOHN E · 公开号 US2010081821US2010081821 · 2010
  2. BERBERINE COMPOUNDS AND PROCESSES FOR THE PREPARATION OF BERBERINE COMPOUNDS
    GROTE CHRISTOPHER W, MOSER FRANK W, JOHNSON JR JOHN E · 公开号 EP2331540EP2331540 · 2011
  3. BERBERINE COMPOUNDS AND PROCESSES FOR THE PREPARATION OF BERBERINE COMPOUNDS
    GROTE CHRISTOPHER W, MOSER FRANK W, JOHNSON JR JOHN E · 公开号 WO2010039215WO2010039215 · 2010
  4. MANGIFERIN-BERBERINE SALT, MANUFACTURING METHOD AND USE THEREOF
    TENG HOULEI, WU WEI · 公开号 WO2010145192WO2010145192 · 2010
  5. Mangiferin-Berberine Salt, Manufacturing Method and Use Thereof
    TENG HOULEI, WU WEI · 公开号 US2012094941US2012094941 · 2012

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

黄莲素 杂质谱研究要点Berberine — impurity profiling notes

下面这些是拿到 黄莲素 的 43 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 43 impurity entries for Berberine, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances